(redirected from tumor necrosis factor)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to tumor necrosis factor: Interleukin 1


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
Hirsch, "Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease," Neuroscience Letters, vol.
The association between tumor necrosis factor, HLA-DR alleles, and IgE-mediated asthma in Taiwanese adolescents.
Activation of coagulation after administration of tumor necrosis factor to normal subjects.
Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cell Immunol.
The anti tumor necrosis factor (anti-TNF) agents involved were infliximab in 40 (44%), etanercept in 37 (40%), and adalimumab in 15 (16%).
Alternatively, elevated levels of tumor necrosis factor and interleukin-1 receptor antagonists on day two after vaccination (7) could be used to monitor the success of vaccinations by primary-care providers in remote areas in the United States (1) and elsewhere.
The drug, sold commercially as Remicade, is a monoclonal antibody that attacks a protein that's made by immune cells called tumor necrosis factor alpha (TNF-alpha).
This class of active agents comprises phosphodiester inhibiting compositions which inhibit any of interleukin 1, interleukin 6 and tumor necrosis factor alpha, which are cytokines that mediate bone resorption.
Factors responsible for this relative resistance to infection and disease include cytotoxic T cells, neutralizing antibodies, high concentrations of certain chemokines (e.g., RANTES, MIP-1), human leukocyte antigen haplotype, mannose-binding protein, and tumor necrosis factor alpha, C4, and TAP polymorphism (2-4).
The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation.

Full browser ?